Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma
Mol Cell
.
2020 Feb 6;77(3):681.
doi: 10.1016/j.molcel.2020.01.005.
Authors
Marie R Webster
,
Mitchell E Fane
,
Gretchen M Alicea
,
Subhasree Basu
,
Andrew V Kossenkov
,
Gloria E Marino
,
Stephen M Douglass
,
Amanpreet Kaur
,
Brett L Ecker
,
Keerthana Gnanapradeepan
,
Abibatou Ndoye
,
Curtis Kugel
,
Alexander Valiga
,
Jessica Palmer
,
Qin Liu
,
Xiaowei Xu
,
Jessicamarie Morris
,
Xiangfan Yin
,
Hong Wu
,
Wei Xu
,
Cathy Zheng
,
Giorgos C Karakousis
,
Ravi K Amaravadi
,
Tara C Mitchell
,
Filipe V Almeida
,
Min Xiao
,
Vito W Rebecca
,
Ying-Jie Wang
,
Lynn M Schuchter
,
Meenhard Herlyn
,
Maureen E Murphy
,
Ashani T Weeraratna
PMID:
32032511
PMCID:
PMC7441646
DOI:
10.1016/j.molcel.2020.01.005
No abstract available
Publication types
Published Erratum
Grants and funding
P30 CA006973/CA/NCI NIH HHS/United States
K99 CA208012/CA/NCI NIH HHS/United States
P30 CA010815/CA/NCI NIH HHS/United States
R50 CA211199/CA/NCI NIH HHS/United States
P50 CA174523/CA/NCI NIH HHS/United States
R01 CA102184/CA/NCI NIH HHS/United States
R01 CA207935/CA/NCI NIH HHS/United States
U01 CA227550/CA/NCI NIH HHS/United States
R00 CA208012/CA/NCI NIH HHS/United States
P01 CA114046/CA/NCI NIH HHS/United States
R01 CA174746/CA/NCI NIH HHS/United States
R01 CA232256/CA/NCI NIH HHS/United States